These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11689777)

  • 1. Long-term immunosuppression and drug interactions.
    Levy GA
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S53-9. PubMed ID: 11689777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression in liver transplantation.
    Cattral MS; Lilly LB; Levy GA
    Semin Liver Dis; 2000; 20(4):523-31. PubMed ID: 11200420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of immunosuppressive drugs in kidney transplantation.
    Salomon DR
    Pharmacotherapy; 1991; 11(6):153S-164S. PubMed ID: 1771141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and evolving immunosuppressive regimens in kidney transplantation.
    Gaston RS
    Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S3-21. PubMed ID: 16567239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney transplantation: the ideal immunosuppression regimen.
    Yabu JM; Vincenti F
    Adv Chronic Kidney Dis; 2009 Jul; 16(4):226-33. PubMed ID: 19576552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression for heart transplantation: where are we now?
    Kobashigawa JA; Patel JK
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):203-12. PubMed ID: 16568129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role and value of sirolimus administration in kidney and liver transplantation.
    Mehrabi A; Fonouni H; Kashfi A; Schmied BM; Morath Ch; Sadeghi M; Schemmer P; Encke J; Sauer P; Zeier M; Weitz J; Büchler MW; Schmidt J
    Clin Transplant; 2006; 20 Suppl 17():30-43. PubMed ID: 17100699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New strategies in immunosuppression.
    Regazzi MB; Alessiani M; Rinaldi M
    Transplant Proc; 2005; 37(6):2675-8. PubMed ID: 16182781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
    Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P
    Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
    Neumann UP; Berg T; Bahra M; Puhl G; Guckelberger O; Langrehr JM; Neuhaus P
    Transplantation; 2004 Jan; 77(2):226-31. PubMed ID: 14742986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral hepatitis after liver transplantation. Which immunosuppressive drugs should be recommended?
    Ciesek S; Manns MP; Wedemeyer H
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):337-50. PubMed ID: 18043552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tolerance in solid organ transplantation: the rationale to develop clinical protocols in liver transplantation.
    Donckier V; Sanchez-Fueyo A; Craciun L; Lucidi V; Buggenhout A; Troisi R; Rogiers X; Bourgeois N; Boon N; Moreno C; Colle I; Van Vlierberghe H; de Hemptinne B; Goldman M
    Transplant Proc; 2009 Mar; 41(2):603-6. PubMed ID: 19328936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of immunosuppression in liver transplantation: contribution of cyclosporine.
    Furukawa H; Todo S
    Transplant Proc; 2004 Mar; 36(2 Suppl):274S-284S. PubMed ID: 15041353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal transplantation, immunosuppression and the skin: an update.
    Moloney FJ; de Freitas D; Conlon PJ; Murphy GM
    Photodermatol Photoimmunol Photomed; 2005 Feb; 21(1):1-8. PubMed ID: 15634217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of immunosuppression withdrawal after liver transplantation.
    Girlanda R; Rela M; Williams R; O'Grady JG; Heaton ND
    Transplant Proc; 2005 May; 37(4):1708-9. PubMed ID: 15919439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance.
    Yang H
    Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S37-51. PubMed ID: 16567240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on liver transplantation using cyclosporine.
    Schrem H; Lück R; Becker T; Nashan B; Klempnauer J
    Transplant Proc; 2004 Nov; 36(9):2525-31. PubMed ID: 15621081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.